Skip to main content

UBS Group AG

Position in MRKR — Marker Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in MRKR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$11,980
-$30,098 QoQ
Shares Held
8,150
-74.8% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 35 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MRKR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. MRKR ranks #442 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MRKR

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,980 8,150
2026-03-31 $42,078 32,369
2025-12-31 $259,297 174,026
2025-09-30 $5,156 5,794
2025-06-30 $2,448 1,600
2025-03-31 $17,602 14,311
2024-09-30 $53,873 19,104
2024-03-31 $1,836 427
2023-09-30 $422 93
2023-06-30 $4,671 1,507
2023-03-31 $3,982 5,609
2022-12-31 $1,013 3,753
2022-09-30 $17,239 46,593
2022-06-30 $1,180 3,578
2022-03-31 $2,600 5,911
2021-12-31 $10,212 10,750
2021-06-30 $24,367 8,734
2021-03-31 $38,536 17,204
2020-12-31 $12,161 8,387
2020-09-30 $6,736 4,491
2020-06-30 $22,759 10,995
2020-03-31 $29,982 15,780